Thomas Griffith Duncan Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 316 Railroad Ave, Goldsboro, MD 21636 Phone: 410-482-2224 Fax: 410-482-2511 |
Morgan Rhodes, DMD Dentist Medicare: Medicare Enrolled Practice Location: 316 Railroad Ave, Goldsboro, MD 21636 Phone: 410-634-2380 |
Anfal Ali, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 316 Railroad Ave, Goldsboro, MD 21636 Phone: 410-754-7583 |
Dr. Yiya Zhou, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 316 Railroad Ave, Goldsboro, MD 21636 Phone: 410-482-2224 Fax: 833-916-1014 |
Marcela Maria Flores Amador, DDS Dentist Medicare: Medicare Enrolled Practice Location: 316 Railroad Ave, Goldsboro, MD 21636 Phone: 410-482-2224 Fax: 410-482-2511 |
Dr. Lindsay Michelle Freedman, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 316 Railroad Ave, Goldsboro, MD 21636 Phone: 104-822-2244 Fax: 833-916-1014 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
Approximately 57 million Americans are on the brink of diabetes. Yet research tells us that there is much we can do to keep it from progressing to full-blown diabetes. Lab tests can help us get a grip on the disease, says the American Clinical Laboratory Association President Alan Mertz.
As new COVID-19 cases continue to rise in 22 states and strain emergency departments nationwide, the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) suggest ER visits in April were down 42% across the country compared to the same period last year.
According to a new report by researchers from UK, the population of Papua New Guinea has the greatest linguistic and genetic diversity. The language differences across the bends of the river Sepik are baffling and reflect and underlying genetic diversity that was until now not fully appreciated. The study report is published today 15th of September 2017 in the journal Science.
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
› Verified 1 days ago